Correlation Between Maxigen Biotech and ReaLy Development

Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and ReaLy Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and ReaLy Development into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maxigen Biotech and ReaLy Development Construction, you can compare the effects of market volatilities on Maxigen Biotech and ReaLy Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of ReaLy Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and ReaLy Development.

Diversification Opportunities for Maxigen Biotech and ReaLy Development

0.51

Correlation Coefficient

Maxigen Biotech  ReaLy Development

Very weak diversification

The 3 months correlation between Maxigen and ReaLy is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and ReaLy Development Construction in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReaLy Development and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with ReaLy Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReaLy Development has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and ReaLy Development go up and down completely randomly.

Pair Corralation between Maxigen Biotech and ReaLy Development

Assuming the 90 days trading horizon Maxigen Biotech is expected to under-perform the ReaLy Development. In addition to that, Maxigen Biotech is 1.62 times more volatile than ReaLy Development Construction. It trades about -0.02 of its total potential returns per unit of risk. ReaLy Development Construction is currently generating about 0.03 per unit of volatility. If you would invest  4,105  in ReaLy Development Construction on December 23, 2024 and sell it today you would earn a total of  90.00  from holding ReaLy Development Construction or generate 2.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Maxigen Biotech  vs.  ReaLy Development Construction

Maxigen Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Maxigen Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Maxigen Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

ReaLy Development

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ReaLy Development Construction are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, ReaLy Development is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Maxigen Biotech and ReaLy Development

The main advantage of trading using opposite Maxigen Biotech and ReaLy Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, ReaLy Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReaLy Development will offset losses from the drop in ReaLy Development's long position.

The idea behind Maxigen Biotech and ReaLy Development Construction pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.